UFP Technologies Inc (UFPT) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of UFP Technologies Inc stock $330, price $303, upside +8.7%, quality 64 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range $57.35 – $358.42 · fair‑value band $200.66 – $420.01 · the $303.47 price screens below the $329.80 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow UFP Technologies in your weekly email
Every Wednesday you see whether UFP Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
Show moreShow less
The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications.
In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs.
The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Stock analysis
UFP Technologies Inc (UFPT) currently trades at $303.47, while our model-based Fair Value estimate is $329.80, so the stock looks roughly fairly valued today (gap 8.0%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $192.76 per share, and 0 of the 24 models we run sit above the $303.47 price.
Bear case: the Earnings-Based group reads lowest at $87.92, and 24 of the 24 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $200.66 (bear) to $420.01 (bull), the price of $303.47 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
UFP Technologies Inc reported revenue of $603M in FY2025 versus $206M in FY2021, a compound +30.7%/yr. Reported net income was $68.3M in FY2025, compounding +44.0%/yr from FY2021.
Key figures
Market cap $2.4B Mid · P/E ratio 31.0 · P/S ratio 3.64 · EPS (TTM) $9.79 · Net margin 11.8% · Return on equity 17.2% · Return on assets (EBIT) 12.4% (5-year average) · Operating margin 16.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 62 out of 100 (low confidence).
What moves the price
The share trades about 9% below its 52-week high and 64% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at 9%, UFPT screens cheaper than that median.
Fair Value models
Bear$200.66Fair Value $329.80Bull$420.01
Price $303.47 · Upside +8.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($8.37 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 6 officers or directors sold shares worth $13.6M and none bought.
SaleMarc D KozinDirector7,000 shares at $304.50$2.1MAug 25, 2026
SaleSymeria HudsonDirector2× since Aug 14, 2026: 2,224 shares, avg. $323.85$720,236Aug 18, 2026
SaleCynthia L FeldmannDirector2× since Jun 12, 2026: 2,200 shares, avg. $277.91$611,409Aug 13, 2026
SaleR Jeffrey BaillyExecutive Chairman, Director2× since Aug 6, 2026: 28,706 shares, avg. $317.36$9.1MAug 10, 2026
SaleJason HoltVice President2× since Dec 10, 2025: 1,200 shares, avg. $308.38$370,058Aug 6, 2026
SaleDaniel C CroteauDirector2,864 shares at $221.71$634,977May 12, 2026
Plus 12 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+19.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.4%
Start year 2020 (pandemic). Over 10 years: +15.8% a year
Revenue growth 34 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+37.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+37.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.33.2% vs 23.6%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 15%
2025 sits 50% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+18.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+6.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +15.9% a year for the price and +3.7% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (97 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 320 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score64 · Above median
Fair Value upside+8.7% · Above median
Profitability
Return on equity (12 months)17.2% · Top 25%
Return on assets10.3% · Top 25%
Net margin (12 months)11.8% · Above median
Operating margin (12 months)16.0% · Above median
Growth and dividend
Revenue growth (quarter YoY)11.6% · Above median
Balance sheet
Debt / equity0.29× · Highest 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (12 months)31.0× · Pricier than median
P/B5.58× · Priciest 25%
P/S (12 months)3.64× · Pricier than median
Price / free cash flow (fiscal year)30.0× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is UFP Technologies Inc (UFPT) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $329.80 versus a price of $303.47, about +9% upside (fairly valued).
What is the fair value of UFPT?
Our model-based fair value for UFP Technologies Inc is $329.80 (as of Nov 6, 2026), built from audited fundamentals. The current price: $303.47.
What is the quality score of UFPT?
UFP Technologies Inc has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UFP Technologies Inc (UFPT)?
Our model-based price target is the fair value of $329.80 (as of Nov 6, 2026) from 24 valuation models. Cautious scenario $200.66, optimistic scenario $420.01. It is a calculation from audited fundamentals, not an analyst target.
What is the UFP Technologies Inc stock forecast for 2026?
Our models put fair value at $329.80, about +9% upside versus a price of $303.47 (fairly valued). Cautious scenario $200.66, optimistic scenario $420.01. The calculation is refreshed regularly with new filings.
What is the revenue of UFP Technologies Inc (UFPT)?
UFP Technologies Inc reported trailing-twelve-month revenue of about $650M (latest available figure, as of Nov 6, 2026).
What growth is priced into UFP Technologies Inc (UFPT)?
For today's price to be fair in a discounted-cash-flow model, UFP Technologies Inc would have to grow free cash flow by +18.7 % per year for five years (discount rate 10.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +27.4 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of UFPT use?
Our models discount UFP Technologies Inc at 10.0 %: a base by market capitalisation (mid), damped by beta 1.10, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For UFP Technologies Inc that is +18.7 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.0 %) and the same formula as our fair value.
How much growth has UFP Technologies Inc (UFPT) delivered so far?
Over the past 5 years revenue at UFP Technologies Inc grew +27.4 % a year. The price currently implies free-cash-flow growth of +18.7 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of UFP Technologies Inc (UFPT) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into UFP Technologies Inc (+18.7 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of UFP Technologies Inc (UFPT)?
The free-cash-flow yield on the price is 3.34 %: that much free cash flow UFP Technologies Inc produces per unit of market value. When it exceeds the discount rate of our models (10.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of UFP Technologies Inc (UFPT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UFP Technologies Inc it is $329.80 per share (as of Nov 6, 2026), against a price of $303.47. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is UFP Technologies Inc stock overvalued or undervalued in 2026?
As of Nov 6, 2026, UFPT trades below its calculated fair value: price $303.47, fair value $329.80, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of UFPT?
No. The price is what the market pays today ($303.47); the fair value is what the company's own numbers justify ($329.80). For UFP Technologies Inc the two are $26.33 per share apart. That gap is exactly why we show both numbers side by side.
How much is UFP Technologies Inc worth?
The market values UFP Technologies Inc at about $2.4B (market capitalisation, as of Nov 6, 2026). Per share that is $303.47; our models calculate a fair value of $329.80 per share.
What do the bullish and bearish scenarios say about UFPT?
Our models span a range for UFP Technologies Inc: cautious scenario $200.66, base $329.80, optimistic $420.01 per share (as of Nov 6, 2026, price $303.47). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of UFPT?
UFP Technologies Inc trades at a price-to-earnings ratio of 31.0 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $329.80 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 5 of the years ex one-offs: 25.9. Other multiples: PEG 3.8, P/B 5.6, P/S 3.6, EV/EBITDA 20.6.
What is the PEG ratio of UFPT?
The PEG ratio of UFP Technologies Inc is 3.80 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of UFP Technologies Inc (UFPT)?
Balance-sheet figures for UFP Technologies Inc (as of Nov 6, 2026): return on equity 17.2%, debt of 0.29 per unit of equity. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is UFPT from its 52-week high?
UFP Technologies Inc trades at $303.47, about 9% below its 52-week high of $334.84 and 64% above the low of $185.45 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $329.80 is for.
Which stocks are comparable to UFP Technologies Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is UFP Technologies Inc stock attractive at the current price?
The data as of Nov 6, 2026: price $303.47, calculated fair value $329.80 (+9%), Quality Score 64/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of UFPT calculated?
We run UFP Technologies Inc through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $329.80 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. UFP Technologies Inc currently trades 8% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of UFP Technologies Inc (UFPT)?
The closing price on Nov 6, 2026 was $303.47. Our model-based fair value is $329.80, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UFP Technologies Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range ($200.66 to $420.01) leaves room in how you read the outcome.
Where does the earnings growth of UFP Technologies Inc (UFPT) come from?
Earnings per share at UFP Technologies Inc grew +24.0 % a year from 2014 to 2025. Broken into its drivers: revenue per share +14.2 %, EBIT margin +6.9 %, tax rate +2.7 %, residual (interest, one-offs) −1.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of UFP Technologies Inc
How large is the market capitalisation of UFP Technologies Inc (UFPT)?
The market capitalisation of UFP Technologies Inc is $2.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of UFP Technologies Inc (UFPT)?
The price-to-sales ratio of UFP Technologies Inc is 3.64 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of UFP Technologies Inc (UFPT)?
Earnings per share at UFP Technologies Inc are $9.79 (price ÷ EPS = P/E 31.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of UFP Technologies Inc (UFPT)?
The net margin of UFP Technologies Inc is 11.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UFP Technologies Inc (UFPT)?
The return on equity (ROE) of UFP Technologies Inc is 17.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UFP Technologies Inc (UFPT)?
On an EBIT basis the return on assets of UFP Technologies Inc is 12.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UFP Technologies Inc (UFPT)?
The operating margin of UFP Technologies Inc is 16.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UFP Technologies Inc (UFPT)?
Revenue at UFP Technologies Inc is growing +11.6% versus a year earlier (3y avg +19.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UFP Technologies Inc (UFPT)?
Earnings per share at UFP Technologies Inc are growing +25.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does UFP Technologies Inc (UFPT) carry?
The net debt of UFP Technologies Inc is $134M (fiscal year 2025, ≈ 1.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch UFP Technologies Inc in the live analysis
One click puts UFP Technologies Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 6, 2026